Beyond the Decade: Strategic Priorities to Reduce the Burden of Musculoskeletal Disease

Jacobs, Joshua J.; King, Toby; Klippel, John H.; Berven, Sigurd; Burr, David B.; Caskey, Paul M.; Elderkin, Ann L.; Esposito, Paul W.; Gall, Eric P.; Goldring, Steven R.; Pollak, Andrew N.; Sandborg, Christy; Templeton, Kimberly

doi:10.2106/jbjs.l.01370

Cited by 27 publications

(24 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ideally, this would be undertaken across jurisdictions to have a nationally aligned approach to addressing the burden of musculoskeletal conditions, such as that proposed by the US Bone and Joint Initiative. 5 In Australia, a national strategy to improve care for people with arthritis called 'A Time to Move' was launched by Arthritis Australia in 2014. Further, targeted and pragmatic research supported by economic and program evaluation will be an additional requirement to support reach, impact and sustainability of MoCs for musculoskeletal health.…”

Section: Models Of Care: the Futurementioning

confidence: 99%

“…Further, targeted and pragmatic research supported by economic and program evaluation will be an additional requirement to support reach, impact and sustainability of MoCs for musculoskeletal health. 5,27 The first step is to understand the purpose of MoCs, now more than ever.…”

Section: Models Of Care: the Futurementioning

confidence: 99%

“…However, a web of evidence now consistently and irrefutably identifies musculoskeletal health conditions and pain of musculoskeletal origin as imparting profound morbidity and socioeconomic burden. [1][2][3][4][5][6] This burden is particularly pronounced in developed nations as evidenced by the 2010 Global Burden of Disease study. 3,6 In Australia, the burden of disease attributed to musculoskeletal conditions now exceeds that of all other chronic health conditions in terms of years lived with disability (a morbidity-only index), and is second only to cancer when considering disability-adjusted life years (a composite index of morbidity and mortality).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Models of care for musculoskeletal health in Australia: now more than ever to drive evidence into health policy and practice

Briggs¹,

Towler²,

Speerin³

et al. 2014

Aust. Health Review

View full text Add to dashboard Cite

Abstract.Musculoskeletal health conditions such as arthritis, osteoporosis and pain syndromes impart a profound socioeconomic burden worldwide, particularly in developed nations such as Australia. Despite the identified burden, substantial evidence-practice and care disparity gaps remain in service delivery and access that limit the potential for improved consumer outcomes and system efficiencies. Addressing these gaps requires a whole-of-sector response, supported by evidence-informed health policy. Models of care (MoCs) serve as a policy vehicle to embed evidence into health policy and guide practice through changes in service delivery systems and clinician behaviour. In Australia, MoCs for musculoskeletal health have been developed by networks of multidisciplinary stakeholders and are incrementally being implemented across health services, facilitated by dedicated policy units and clinical champions. A web of evidence is now emerging to support this approach to driving evidence into health policy and practice. Understanding the vernacular of MoCs and the development and implementation of MoCs is important to embracing this approach to health policy.What is known about the topic? The impact of musculoskeletal health conditions is profound. As the awareness around the magnitude of the impact of these conditions increases, the importance of system-wide policy responses and platforms for health service improvements is now recognised. The term 'models of care' is not new. It has been used for many years, mainly at the hospital level, for planning and delivering clinical services. However, over the past 8 years an alternative approach using health networks has been adopted for the development and implementation of models of care to achieve broad engagement and a wider and more sustainable scope for implementation. What does this paper add? Here, we provide a rationale for the development of models of care for musculoskeletal health and draw on experience in their development and implementation using a health network model, referring to an emerging web of evidence to support this approach. We describe what models of care are, how they are developed and question whether they make a difference and what the future may hold. What are the implications for practitioners? All indications suggest that models of care are here to stay. Therefore, this paper provides practitioners with a contemporary overview of models of care in Australia, their relevance to musculoskeletal healthcare, particularly related to closing evidence-practice gaps, and opportunities for sector engagement.

show abstract

Section: Models Of Care: the Futurementioning

confidence: 99%

Section: Models Of Care: the Futurementioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Models of care for musculoskeletal health in Australia: now more than ever to drive evidence into health policy and practice

Briggs¹,

Towler²,

Speerin³

et al. 2014

Aust. Health Review

View full text Add to dashboard Cite

show abstract

“…9 However, a mismatch remains between the burden of these conditions and the investment in research to address it, in every region of the world. 10 For example, although a review of Australian National Health and Medical Research Council (NHMRC) funding found that >AU$237 million had been invested in arthritis and osteoporosis research from 2005 to 2014, 11 this was significantly less than was spent on other Australian National Health Priority Areas, such as diabetes (>$584 million) and cardiovascular disease (>$933 million). Furthermore, a review of the scope of Australian musculoskeletal clinical trials found that the NHMRC had funded an average of 5.8 new musculoskeletal trials per year between 2008 and 2013 through their project grant scheme, representing just 0.8% of all project grants and only 5% of all NHMRC clinical trial funding.…”

Section: Introductionmentioning

confidence: 99%

Setting the research agenda for improving health care in musculoskeletal disorders

2015

View full text Add to dashboard Cite

Despite a substantial contribution to the global burden of disease, musculoskeletal conditions are under-represented in clinical research, and that which is performed is often wasteful and lacking clinical relevance. Even clinically relevant musculoskeletal research might not lead to timely or adequate changes in clinical practice and associated improvements in patient outcomes. The formulation of clinical recommendations alone is usually insufficient to bring about changes in practice patterns. Research exploring how to improve the translation of evidence-based recommendations into practice, as well as the identification and removal of barriers to practice change, is necessary in order for the promise of musculoskeletal research to be realized in improved health outcomes. These goals can be achieved by improvements in the coordination of research activities, the resourcing and allocation of funding, and the involvement of clinicians and patients.

show abstract

“…In 2007, in the United States, medicines for OA cost $5.31 billion dollars (Intercontinental Marketing Service data), and musculoskeletal conditions including OA resulted in nearly $86.2 billion in direct medical expenses, i.e., total joint replacement procedures and loss of income and production. Hence, 2000-2010 was called the decade of bone and joint to launch global awareness and promote further research in prevention, diagnosis, and treatment of joint injuries and currently move beyond the decade strategic priorities to reduce the burden of musculoskeletal disease (Jacobs et al 2013).…”

Section: Introductionmentioning

confidence: 99%

Platelet-Rich Plasma in the Treatment of Cartilage Defects and Early Osteoarthritis of the Knee

Gobbi¹,

Karnatzikos²,

Lad³

2015

Sports Injuries

View full text Add to dashboard Cite

Beyond the Decade: Strategic Priorities to Reduce the Burden of Musculoskeletal Disease

Cited by 27 publications

References 1 publication

Models of care for musculoskeletal health in Australia: now more than ever to drive evidence into health policy and practice

Models of care for musculoskeletal health in Australia: now more than ever to drive evidence into health policy and practice

Setting the research agenda for improving health care in musculoskeletal disorders

Platelet-Rich Plasma in the Treatment of Cartilage Defects and Early Osteoarthritis of the Knee

Contact Info

Product

Resources

About